Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
Classement en actions #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Prix de l'action
$0.1458359
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$85.87M
Changement (1 jour)
-1.30%
Changement (1 an)
-38.40%
Pays
HK
Échange Lee's Pharmaceutical Holdings Limited (0950)

Catégorie

Le prix 0950 avec la capitalisation boursière de B
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
0950
$0.1458359
Capitalisation boursière de Lee's Pharmaceutical Holdings Limited(0950)
Capitalisation boursière: $85.87M
En August 2026, Lee's Pharmaceutical Holdings Limited a une capitalisation boursière de $85.87M. Cela fait de Lee's Pharmaceutical Holdings Limited la 22620th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Lee's Pharmaceutical Holdings Limited du 2002 au 2026
0950 par rapport au top 5 des plus populaires stocks
Prix pour 0950 L’actif B La capitalisation boursière de B Résultats
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$8,850.34 $85.87M
$5.211T +6,068,594.72%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,721.62 $85.87M
$4.547T +5,294,634.25%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,069.03 $85.87M
$4.162T +4,847,147.71%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$6,101.55 $85.87M
$3.593T +4,183,743.16%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$4,743.03 $85.87M
$2.793T +3,252,208.68%